logo
Select company
Select metric
$ 246KNet Cash Flow - Financing
VS
Market
46
Sector
68
Industry
80
History
89
$ 1.82Close
$ 0.9 - $ 3.97 52-Week Range
Ticker Information

Ticker

RPTX

Company Name

REPARE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REPARE THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RPTX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 246K
3/31/2025$ 246K
12/31/2024$ 542K
9/30/2024$ 646K
6/30/2024$ 764K
3/31/2024$ 804K
12/31/2023$ 842K
9/30/2023$ 902K
6/30/2023$ 887K
3/31/2023$ 1.05M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REPARE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 247.84M.
  • Over the past 5 years, REPARE THERAPEUTICS INC's average CF - Financing has been $ 46.62M.
  • The median CF - Financing for REPARE THERAPEUTICS INC during this period was $ 887K
  • REPARE THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 247.84M.
  • The lowest CF - Financing recorded by REPARE THERAPEUTICS INC in the same timeframe $ -774K

REPARE THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
COEP : COEPTIS THERAPEUTICS HOLDINGS INC $ 8.43MINO : INOVIO PHARMACEUTICALS INC $ 30.8MMNOV : MEDICINOVA INC $ 0APLT : APPLIED THERAPEUTICS INC $ 0ENTX : ENTERA BIO LTD $ 16.52MCLNN : CLENE INC $ 3.27MABVC : ABVC BIOPHARMA INC $ 2.79MSER : SERINA THERAPEUTICS INC $ 15.6MINMB : INMUNE BIO INC $ 35.26MABP : ABPRO HOLDINGS INC $ 9.74M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

RPTX - Net Cash Flow - Financing, Last 5 years

$ -774K

Minimum

Jun 30, 2021

$ 247.84M

Maximum

Dec 31, 2020

$ 46.62M

Average

$ 887K

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.85M with a standard deviation of $ 119.31M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -367.1M
max$ 366M
average$ -6.85M
median$ 305K
std$ 119.31M